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Hepatitis delta antigen (HDAg) of hepatitis delta virus (HDV) typically consists of two related protein species. The small
HDAg (S-HDAg) is a 24-kDa protein of 195 amino acids and the large HDAg (L-HDAg) is a 27-kDa protein with an additional
19 amino acids at its C-terminus. These two proteins have distinct functions in the HDV life cycle. We have developed
conditions for expressing S-HDAg and L-HDAg in E. coli as soluble proteins to facilitate large-scale purification. These
proteins were purified to homogeneity and shown to be biologically active. Transfection of the purified recombinant S-HDAg
together with HDV genomic RNA resulted in viral RNA replication. Surprisingly, the purified S-HDAg could not initiate
replication from the antigenomic-sense HDV RNA, even though the latter led to RNA replication when transfected with an
mRNA encoding the S-HDAg. These results suggest that initiation of HDV RNA synthesis from the antigenomic RNA may
require a form of HDAg that is modified in mammalian cells; in contrast, RNA synthesis from the genomic RNA could be
initiated by the recombinant S-HDAg from E. coli. Interestingly, the purified L-HDAg appeared as multiple protein species,
including one corresponding to S-HDAg, probably as a result of degradation. The partially proteolyzed L-HDAg also initiated
HDV RNA replication under the same conditions. These results add to the mounting evidence that genomic- and antigenomic-
strand HDV RNA syntheses are carried out by different mechanisms. © 2000 Academic Press
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Hepatitis delta virus (HDV) is a 36-nm particle, which
contains a circular, viroid-like RNA genome. This single-
stranded RNA is approximately 1700 nucleotides long,
with a high degree of intramolecular base-pairing, and is
associated with hepatitis delta antigen (HDAg) (Bonino
et al., 1986; Kos et al., 1986; Makino et al., 1987; Rizzetto
et al., 1980; Wang et al., 1986). In the infected cells, an
antigenomic RNA species, usually in a lower amount
than the genomic RNA, is also found (Chen et al., 1986).
The virus is defective and always associated with hep-
atitis B virus (HBV) infection, since HDV depends on HBV
to provide hepatitis B surface antigen (HBsAg) to form
the viral envelope (Rizzetto, 1983). Coinfection of HDV
with HBV causes severe and often fatal liver disease in
human, and is the most common cause of fulminant viral
hepatitis (Hoofnagle, 1989). HDAg is encoded from the
antigenomic strand of the viral RNA and is detected in
the nuclei of the infected cells (Rizzetto et al., 1977).
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578HDAg usually consists of two protein species: a 24-kDa
(195 amino acids) small delta antigen (S-HDAg) and a
27-kDa (214 amino acids) large delta antigen (L-HDAg)
(Bergmann and Gerin, 1986; Bonino et al., 1986; Pohl et
al., 1987). These two proteins are identical in sequence,
except that the L-HDAg contains 19 additional amino
acids at the C-terminus. A single nucleotide at the amber
termination codon of the open reading frame (ORF) for
S-HDAg on the antigenomic RNA strand is edited during
HDV RNA replication, so that the ORF extends for 19
additional amino acids to encode L-HDAg (Luo et al.,
1990). Indeed, in every patient examined, both HDV RNA
species encoding L-HDAg and S-HDAg are detected (Xia
et al., 1990).
L-HDAg and S-HDAg contain several structural do-
mains: (1) a coiled-coil structure consisting of four
leucines or isoleucines, each separated by six amino
acids. This leucine-zipper motif enables HDAg to form
dimers and oligomers either with itself or between S-
HDAg and L-HDAg (Chang et al., 1993; Wang and Lemon,
1993; Xia and Lai, 1992); (2) a nuclear localization signal
(NLS) located between amino acids 68 and 88 from the
N-terminus (Xia et al., 1992); (3) an RNA-binding domain
consisting of two stretches of arginine-rich motifs from
amino acids 95 to 146 (Lai, 1995; Lee et al., 1993). An-
other stretch of sequence located between amino acids
2 and 27 from the N-terminus also contains a cryptic
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579RECOMBINANT HEPATITIS DELTA ANTIGEN AND RNA REPLICATIONRNA-binding activity (Poisson et al., 1993). Deletion of the
LS or all three of the RNA-binding motifs of HDAg
esulted in the failure of nuclear import of HDV RNA. Any
ne of the three RNA-binding motifs is sufficient to me-
iate the nuclear transportation of HDV RNA (Chou et al.,
998).
The C-terminus of L-HDAg contains a stretch of 19
dditional amino acids that is unique to L-HDAg. The
ourth amino acid from the C-terminus is a cysteine
esidue. This constitutes an isoprenylation signal, which
irects the prenylation of L-HDAg with a farnesyl group
Glenn et al., 1992; Otto and Casey, 1996). This modifica-
ion enables the L-HDAg to interact with the HBsAg
Hwang and Lai, 1993a). The presence of isoprenylate
lters the conformation of HDAg, particularly near its
-terminus (Hwang and Lai, 1994). Both the S-HDAg and
-HDAg are also modified by phosphorylation, although
he L-HDAg is phosphorylated to a greater extent
Hwang et al., 1992).
Despite the structural similarities between the two
ntigen species, they have very distinct biological activ-
ties. S-HDAg is required for HDV RNA replication (Kuo et
l., 1989). In contrast, L-HDAg inhibits HDV RNA replica-
ion, an activity that depends on the ability of L-HDAg to
orm a complex with S-HDAg (Chao et al., 1990; Xia and
ai, 1992). This view, however, was recently refined to
eflect the finding that L-HDAg inhibits only the genomic-
trand, but not the antigenomic-strand, HDV RNA synthe-
is (Modahl and Lai, 2000). Another function of L-HDAg is
n HDV particle assembly (Chang et al., 1991; Ryu et al.,
992; Sureau et al., 1994), as the presence of isopreny-
ated L-HDAg is essential for virion assembly (Glenn et
l., 1992; Lee et al., 1994).
To study the molecular and structural basis for the
istinct functions of these two proteins, it is desirable to
erform biochemical and biophysical analysis of the pu-
ified proteins. For this purpose, we have begun large-
cale expression and purification of the recombinant
DAg. Previous attempts at expressing HDAg were
lagued by the insolubility of the protein. Furthermore,
urification of HDAg has been difficult because of the
endency of HDAg to aggregate and complex with other
olecules. In this study, we determined the optimum
onditions for the expression of these proteins as solu-
le proteins in E. coli. We also developed procedures to
urify S-HDAg to apparent homogeneity as a functionally
ctive protein, capable of initiating HDV replication from
he viral genomic-sense RNA. In contrast, L-HDAg was
xpressed poorly. Nevertheless, we purified a limited
mount of soluble L-HDAg, which was found to be highly
usceptible to proteolysis. These purified proteins re-
ealed surprising differences in the requirements fornitiation of HDV RNA replication from the genomic and
he antigenomic HDV RNA strands.RESULTS
xpression and purification of the recombinant
-HDAg
The expression plasmid for S-HDAg was transformed
nto E. coli BL21DE3 and the E. coli cells were grown at
28°C for 18 h after IPTG induction. We observed that at
28°C, the expression level of S-HDAg was much higher
than that at 37°C. Although the predicted pI value of
S-HDAg is 9.76, S-HDAg bound very strongly to DE-52
(anion exchange resin) at pH 7.4. To purify S-HDAg, we
performed two cycles of chromatography on DE-52 col-
umns. In the first cycle, S-HDAg was eluted with one-step
elution buffer in the presence of 750 mM salt (Fig. 1A). In
the second cycle, a smaller volume of DE-52 resin was
used and S-HDAg was eluted with a linear salt gradient;
S-HDAg was eluted at 200 mM salt concentration (Fig.
1B).
To further purify S-HDAg, several different ion-ex-
change chromatography procedures were attempted,
but none of them gave satisfactory results. When phos-
FIG. 1. Purification of the recombinant S-HDAg. (A) First DEAE-
cellulose chromatography. (B) Second DEAE-cellulose chromatogra-
phy. (C) Phosphocellulose chromatography. The recombinant S-HDAg
was purified as described under Materials and Methods. Aliquots of
the fractions were analyzed on a 12.5% SDS–polyacrylamide gel. Pro-
teins were visualized by staining with Coomassie blue. FT is the
flowthrough. S is the starting sample. The arrow indicates S-HDAg.phocellulose resin was used, S-HDAg could be eluted
with 1 M salt but the yield was low and the protein was
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580 SHEU AND LAInot pure. We found, instead, that it could be eluted
efficiently by 0.2 M K2HPO4 (Fig. 1C).
S-HDAg eluted from the phosphocellulose column
as concentrated using a small SP–Sepharose HP col-
mn and then used for gel filtration on Superose 12.
-HDAg was eluted as a large molecule near the void
olume in the presence of 1 M NaCl and 0.1% Triton
-100 (Fig. 2). However, when 150 mM NaCl was used as
uffer, no distinct peaks of S-HDAg could be identified;
nstead, S-HDAg was detected in every fraction (data not
hown). These data indicated that S-HDAg formed a
arge homo-multimeric complex under high ionic condi-
ions, but formed more heterogeneous multimers under
ow ionic conditions. Throughout the purification pro-
ess, the identity of HDAg was ascertained by immuno-
lotting with an HDAg-specific antibody.
These results showed that S-HDAg could be purified
s a soluble and homogeneous multimeric protein from
. coli BL21DE3 cells by two cycles of DE-52 chromatog-
aphy, phosphocellulose chromatography, and gel filtra-
ion, followed by SP–Sepharose chromatography (Fig.
A). The purity of the recombinant S-HDAg was exam-
ned by silver staining, which revealed a single protein
pecies (Fig. 3B). Table 1 summarizes the yields and
urity of S-HDAg recovered from each chromatography
tep.
xpression and purification of L-HDAg
We next performed similar studies on L-HDAg. The
xpression level of L-HDAg in BL21DE3 cells was very
ow at either 37 or 28°C. Nevertheless, L-HDAg was
xpressed as a soluble protein and could be detected by
estern blot analysis. By using the same strategy as for
-HDAg, L-HDAg was purified through two cycles of
E-52 chromatography and phosphocellulose chroma-
ography. We observed that L-HDAg was associated with
ore cellular proteins than those with S-HDAg at the
ame steps of purification (data not shown). Western blot
FIG. 2. Analysis of the recombinant S-HDAg by gel filtration on
Superose 12 column. The protein molecular-weight standards were
blue dextran (Vo), gamma globulin (160 kDa), bovine serum albumin (68
kDa), and cytochrome C (12.4 kDa). Proteins were visualized by stain-
ing with Coomassie blue. S denotes S-HDAg.nalysis showed that, in addition to p27 (L-HDAg), sev-
ral smaller protein species reacting with the HDAg- Mpecific antibody were detected after the third step (P11
hromatography) (Fig. 4A), suggesting that the L-HDAg
as partially degraded during purification. When L-HDAg
as further purified with UNO-S chromatography (Fig.
B), L-HDAg was found to be further degraded into mul-
iple smaller-sized proteins, one of which corresponds to
-HDAg (p24) in size. The identity of this protein as an
-HDAg-like protein was established by immunoblotting
sing a monoclonal antibody (9E4) that specifically rec-
gnizes the last several amino acids of S-HDAg, but not
-HDAg, because of conformational differences (Hwang
nd Lai, 1993b). Interestingly, this monoclonal antibody
ecognized this truncated protein (p24) but not the full-
ength L-HDAg (p27); nor did it detect smaller protein
pecies derived from L-HDAg (Fig. 4C). Thus, p24 has a
onformation similar to that of the native S-HDAg. These
esults indicated that S-HDAg-like protein could be de-
FIG. 3. Comparison of S-HDAg at each chromatography step. (A)
Aliquots from supernatant (S) and pellet (P) of E. coli after sonication
and centrifugation, the first DEAE-cellulose chromatography (DE-1), the
second DEAE-cellulose chromatography (DE-2), phosphocellulose
chromatography (P11), and concentrated S-HDAg from Superose 12
(SP) were analyzed on a 12.5% SDS–polyacrylamide gel. Proteins were
visualized by staining with Coomassie blue. (B) Silver staining of S-
HDAg (0.5 mg) after gel filtration.
TABLE 1
Purification of S-HDAg from 1 L LB Medium of E. coli Cells
Sample
Volume
(ml)
Protein
concentration
(mg/ml)
Total
protein
(mg)
Yield
(%)
Relative
purity
(%)
Supernate 60 6.3 378,000 100 2
DEAE-cellulose
chromatography I 150 1.9 307,500 81.3 8
DEAE-cellulose
chromatography II 76 1.6 144,400 38.2 16
Phosphocellulose
chromatography 41 0.57 23,370 6.2 85
Gel filtration and
SP–Sepharose
chromatography 3.4 2.2 7,400 1.9 98Note. Purification procedures are described under Materials and
ethods.
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581RECOMBINANT HEPATITIS DELTA ANTIGEN AND RNA REPLICATIONrived from proteolytic cleavage of L-HDAg. This finding is
consistent with the previous finding that HDAg extracted
from HDV-infected liver tissue of humans, chimpanzees,
and woodchucks degraded rapidly (Wang and Lemon,
1993). Thus, the degradation of the recombinant L-HDAg
during purification probably is not an artifact of improper
handling of the protein but, rather, reflects an intrinsic
property of L-HDAg. We found that S-HDAg is more
stable than L-HDAg under the same conditions.
Initiation of HDV replication by recombinant S-HDAg
and L-HDAg
To characterize the functional activity of the recombi-
nant HDAg purified from E. coli, we examined the ability
f the purified S-HDAg to initiate HDV RNA replication by
n RNA–protein (RNP) complex transfection assay (Din-
le et al., 1998). The genomic HDV RNA (1.9 kb, which
ontains one genomic copy plus an additional copy of
he ribozyme domain) was mixed with the purified S-
DAg and transfected into Cos7 cells, after which the
tate of viral RNA was examined by Northern blotting
nalysis. The antigenomic-sense, monomeric-size (1.7-
b) HDV RNA was detected on Day 3 posttransfection,
ndicating that HDV RNA had replicated. As a control,
ransfection with genomic RNA alone without S-HDAg
id not lead to RNA replication (Fig. 5). This result indi-
ates that the purified recombinant S-HDAg is function-
lly active. We also performed immunoblotting of HDAg
n the transfected cells. The results showed that S-HDAg
as detectable throughout the experiment, although
ome of the protein at the early time points was likely
erived from the transfected S-HDAg (data not shown).
FIG. 4. Purification of the recombinant L-HDAg. (A) Lane 1 is the
hromatography; and lane 3 is an aliquot from P11 chromatography. T
olyclonal antibody. (B) Lane 1 is L-HDAg expressed in Sf-9 cells from
. coli and purified from UNO-S chromatography. HDAg was detected
roteins of (B) were detected with S-HDAg-specific 9E4 monoclonal ahe L-HDAg, which is made from the edited HDV RNA
uring HDV replication (Luo et al., 1990), became detect-ble at Day 4 posttransfection, indicating that HDV RNA
eplication indeed occurred (data not shown).
Surprisingly, when L-HDAg together with the genomic
DV RNA was used for transfection, the monomeric-size
ntigenomic RNA of HDV was also detected by Northern
lot analysis, although it was not as abundant as that
hen S-HDAg was used (Fig. 6A). To confirm that HDV
NA synthesis occurred, we also performed Western
lotting of HDAg on Day 6 posttransfection, when the
ransfected HDAg was usually not detectable. The re-
ults showed that both L-HDAg and S-HDAg were de-
ectable. The relative ratio between the two species was
imilar to, although the amounts were lower than, those
hen S-HDAg was used for transfection (Fig. 6B). These
esults suggest that the S-HDAg-like molecule detected
n the L-HDAg preparation (Fig. 4) was functionally simi-
atant of E. coli lysate; lane 2 is an aliquot from the second DE-52
tein was detected by Western blotting using an HDAg-specific rabbit
virus system (Hwang et al., 1992), and lane 2 is L-HDAg expressed in
munoblotting using HDAg-specific polyclonal antibody. (C) The same
(Hwang and Lai, 1993b).
FIG. 5. Initiation of HDV RNA replication by the recombinant S-HDAg.
HDV genomic RNA (G-RNA) (1.9 kb) with or without the purified recom-
binant S-HDAg were cotransfected into Cos7 cells. RNA was extracted
from the transfected cells at various time points posttransfection.
Northern blot analysis was performed to detect antigenomic-sense
RNA. Lane 1 is RNA from Huh-7 cells cotransfected with HDV genomicsupern
he pro
baculoRNA and mRNA for S-HDAg to serve as a marker (Modahl and Lai,
1998).
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582 SHEU AND LAIlar to the authentic S-HDAg. Since HDV RNA replication
took place, even though the purified L-HDAg preparation
contained more L-HDAg than S-HDAg (p24) (Fig. 4),
these results further indicated that L-HDAg did not inhibit
HDV RNA replication significantly, confirming our recent
report that L-HDAg inhibits genomic, but not the antige-
nomic, HDV RNA synthesis (Modahl and Lai, 2000).
Recombinant S-HDAg specifically initiates the
replication of genomic-sense HDV RNA, but not the
antigenomic-sense HDV RNA
The above-noted results showed that the recombinant
S-HDAg was able to initiate HDV replication using
genomic-sense RNA. This is compatible with the fact that
HDV virion contains genomic-sense RNA only (Kos et al.,
1986; Makino et al., 1987; Wang et al., 1986). Next, we
ere interested to know whether the purified S-HDAg
ould also initiate RNA replication by using antigenomic-
ense HDV RNA. Surprisingly, while the RNP complex
ontaining the 1.9-kb genomic-sense RNAs was able to
nitiate RNA replication (Fig. 7, lane 1), no RNA replica-
ion was observed when the corresponding antigenomic
NA was used (Fig. 7, lane 2). This result was confirmed
sing the RNP complex containing the HDV RNA dimer
3.4 kb); only the genomic-strand dimer RNA, but not the
ntigenomic dimer, could initiate RNA replication (Fig. 7,
anes 3 and 4). To rule out the possibility that the in
itro-transcribed antigenomic RNA contained unidenti-
ied defects, we performed an RNA transfection experi-
ent by cotransfecting the antigenomic 1.9-kb HDV RNA
nd an mRNA encoding S-HDAg according to the pub-
ished method (Modahl and Lai, 1998). Consistent with
ur previous findings (Modahl and Lai, 2000), the results
FIG. 6. Initiation of HDV RNA replication by the recombinant L-HDAg.
HDV genomic RNA (1.9 kb) and the purified L-HDAg were cotransfected
into Cos7 cells and analyzed by Northern blot analysis (A) for antige-
nomic-sense RNA and Western blot analysis (B) for HDAg. Lane 1
shows transfection of the L-HDAg–RNA complex; lane 2 shows trans-
fection of the S-HDAg–RNA complex. Cos7 cells were harvested 6 days
posttransfection.howed that HDV RNA replication (Fig. 7, lane 5) oc-
urred, indicating the integrity of the antigenomic RNAsed in this experiment. Thus, the recombinant HDAg
repared from E. coli was able to initiate HDV RNA
eplication from the genomic RNA but not from the anti-
enomic RNA, implying that the initiation of RNA synthe-
is from the antigenomic HDV RNA requires an HDAg
ynthesized in the cells. This finding further suggests
hat genomic and antigenomic RNA syntheses have dif-
erent requirements.
We also used a 1.9-kb HDV genomic RNA containing
n ORF for L-HDAg for transfection. We found that the
ecombinant S-HDAg could not initiate RNA replication
rom this RNA (data not shown). This result is consistent
ith the results obtained from the RNA transfection ex-
eriments using this 1.9-kb RNA and the mRNA encoding
-HDAg (Macnaughton and Lai, unpublished data). Thus,
he purified recombinant S-HDAg could initiate HDV RNA
eplication only from HDV RNAs that contain an ORF for
-HDAg. These combined results indicate that the inabil-
ty of the recombinant S-HDAg to initiate RNA replication
rom the antigenomic RNA most likely reflects the true
roperties of HDAg.
DISCUSSION
Studies of the biochemical and biophysical properties
f HDAg have so far been hampered by the scarcity of
he purified HDAg. We previously expressed a recombi-
ant HDAg using a baculovirus system, although the
xpressed HDAg was not a soluble protein (Hwang et al.,
992). In this study, we used the E. coli expression
ystem and successfully obtained large amounts of sol-
ble S-HDAg for in vitro biochemical and biological char-
cterization. After two cycles of DEAE-cellulose chroma-
FIG. 7. Genomic-sense-specific HDV RNP initiation of HDV replica-
tion. The purified S-HDAg was cotransfected with various HDV RNA
species into Cos7 cells; cellular RNA was harvested at 6 days post-
transfection for Northern blot analysis to detect antigenomic RNA
species. (The transfected RNA was no longer detectable at this time.)
G-1 is genomic-sense monomeric 1.9-kb HDV RNA and AG-1 is anti-
genomic-sense monomeric 1.9-kb HDV RNA. G-2 is genomic-sense
HDV RNA dimer and AG-2 is antigenomic-sense HDV RNA dimer.
mRNA is the capped mRNA encoding S-HDAg (Modahl and Lai, 1998).
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583RECOMBINANT HEPATITIS DELTA ANTIGEN AND RNA REPLICATIONtography and phosphocellulose chromatography,
S-HDAg was purified to apparent homogeneity. Approx-
imately 7 mg of S-HDAg could be obtained from 1 L of E.
coli LB culture medium. When the purified recombinant
S-HDAg was analyzed with gel filtration chromatography,
the S-HDAg migrated as a large molecule with a molec-
ular mass of approximately 1 3 106 Da. This molecular
ize is comparable to the estimated molecular weight of
3 105 2 1 3 106 Da for the HDAg isolated from the
ammalian cells (Macnaughton et al., 1990). This large
apparent molecular size reflects the ability of HDAg to
form multimers (Roggendorf et al., 1987; Wang and
Lemon, 1993; Xia and Lai, 1992).
Previously, Dingle et al. (1998) reported the expression
of HDAg in E. coli by optimizing the codons of S-HDAg for
expression in E. coli. The purified recombinant S-HDAg
was able to initiate HDV replication, but the detail of the
purification data and the degree of purity were not re-
ported. In this study, we showed that S-HDAg can be
efficiently expressed in E. coli without alteration of the
codons, and that the application of phosphocellulose
chromatography significantly improved the quality and
quantity of HDAg purification. Thus, the pattern of codon
usage in E. coli is not the mitigating factor for the poor
expression of the protein in E. coli.
It is not clear why L-HDAg could not be efficiently
expressed in E. coli. Surprisingly, L-HDAg was easily
degraded during purification. Using similar purification
procedures to those for S-HDAg, L-HDAg was obtained
as a partially proteolyzed protein mixture which includes
27- and 24-kDa and several smaller HDAg-related frag-
ments.
The purified S-HDAg was able to initiate HDV RNA
replication, when it was transfected together with HDV
genomic RNA into Cos7 cells. This finding suggests that
recombinant S-HDAg and HDV RNA may form a correct
RNP, which allows the initiation of HDV RNA replication.
Thus, the purified S-HDAg has preserved its biological
functions. It was surprising that our L-HDAg preparation
was also able to initiate HDV replication. The ability of
the recombinant L-HDAg to initiate RNA replication prob-
ably stemmed from the fact that an S-HDAg-like mole-
cule was generated from L-HDAg by proteolytic cleavage
during purification. This conclusion was confirmed by the
finding that the 24-kDa protein in the purified L-HDAg
preparation reacted with a monoclonal antibody that
specifically recognizes S-HDAg but not L-HDAg. Al-
though it is not clear whether the degradation of L-HDAg
into S-HDAg could occur during the natural HDV life
cycle, such degradation was previously observed during
the isolation of HDAg from the HDV-infected liver
(Roggendorf et al., 1987; Wang and Lemon, 1993). Con-
ceivably, such degradation may occur in vivo under some
circumstances, which may contribute to HDV RNA repli-
cation. L-HDAg was known to be an inhibitor of HDV
replication; as little as 10% of L-HDAg relative to S-HDAg
t
rwas reported to inhibit HDV replication (Chao et al.,
1990). However, our recent study using an RNA transfec-
tion system showed that L-HDAg had a much weaker
inhibitory activity on the initiation of antigenomic RNA
synthesis than on the genomic RNA synthesis (Modahl
and Lai, 2000). The ability of the partially degraded re-
combinant L-HDAg to initiate HDV RNA synthesis follow-
ing RNP transfection, despite the fact that it contained
more L-HDAg than S-HDAg, lends further support to our
conclusion that L-HDAg does not effectively inhibit anti-
genomic RNA synthesis.
The recombinant S-HDAg purified by Dingle et al.
(1998) was claimed to be able to initiate both genomic
and antigenomic HDV RNA syntheses, although the data
based on antigenomic RNA transfection were not shown.
The reason for the discrepancy between these results is
not clear. Since S-HDAg expressed from an mRNA in the
cells could initiate HDV RNA replication from the antige-
nomic RNA (Fig. 7) (Modahl and Lai, 2000), whereas our
purified recombinant S-HDAg from E. coli could not,
these two forms of S-HDAg most likely have different
properties. One possibility is that S-HDAg expressed in
the mammalian cells is posttranslationally modified, and
only the modified form can initiate RNA synthesis from
the antigenomic-sense RNA. We attempted to phosphor-
ylate the recombinant S-HDAg by casein kinase II and
then examined the ability of the phosphorylated S-HDAg
to promote RNA replication of the HDV antigenomic RNA;
no RNA replication was observed (unpublished data).
Thus, other types of modification may be required for
S-HDAg to initiate RNA synthesis from the antigenomic
RNA template. This observation is consistent with the life
cycle of HDV, that is, HDV virion contains the genomic-
sense RNA and HDAg; thus, the initial HDV antigenomic
RNA synthesis must occur on the preformed RNP com-
plex. In contrast, HDV genomic RNA synthesis from the
antigenomic RNA template occurs after new HDAg has
been synthesized from the de novo-transcribed 0.8-kb
mRNA (Chen et al., 1986). Therefore, conceptually, these
two types of RNA synthesis may involve different mecha-
nisms.
Indeed, we recently found that HDV genomic and an-
tigenomic RNA syntheses have different enzymatic re-
quirements; that is, genomic RNA synthesis is inhibited
by a low concentration of a-amanitin, whereas antigeno-
ic RNA synthesis is resistant (Modahl and Lai, unpub-
ished observations). Furthermore, genomic RNA synthe-
is is sensitive to inhibition by L-HDAg, whereas antige-
omic RNA synthesis is resistant (Modahl and Lai, 2000).
n addition, the synthesis of the antigenomic RNA and
he transcription of mRNA have different sensitivities to
a-amanitin (Modahl et al., 2000). All these findings indi-
ate that the different HDV RNA species are synthesized
y different mechanisms. The finding reported here thathe HDV genomic and antigenomic RNA syntheses may
equire different forms of S-HDAg adds to this growing
L
a
L
c
a
w
A
S
S
g
T
o
f
l
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tion of HDV genomic and antigenomic RNA syntheses.
HDV replication has been studied so far mainly by
using cDNA transfection. One of the major complications
of this approach was the difficulty in distinguishing DNA-
dependent transcription from RNA-dependent RNA syn-
thesis. The recently developed RNA-transfection ap-
proach obviates this problem (Modahl and Lai, 1998).
The RNP complex transfection assay provides another
alternative approach for studying RNA-dependent RNA
synthesis of HDV. The availability of a large quantity of
the purified HDAg makes such an approach practical.
The HDAg purified from E. coli may also be used as a
diagnostic tool for immunological studies.
MATERIALS AND METHODS
Plasmid construction
To construct the S-HDAg expression vector, PX9 plas-
mid (Chang et al., 1988) was used as the template for
PCR amplification. A primer containing an NdeI site (59-
TATACATATGAGCCGGTCCGAA-39) at the 59-end and a
primer containing a BamHI site (39-GTCCCTAATAGGG-
59) at the 39-end of the ORF were used to amplify the ORF
of S-HDAg. For the L-HDAg expression vector, the same
NdeI site-containing primer was used along with a
primer containing a BamHI site at the 39-end of the ORF
for L-HDAg (39-ACAGCTGGGGTCACTCCTAGGG-59). The
template for PCR amplification of the L-HDAg ORF was
from a recombinant baculovirus, PAcYM1-L-HDAg
(Hwang et al., 1992), expressing L-HDAg. After 25-cycle
PCR amplification, the DNA product was digested with
NdeI and BamHI and subcloned into PET3a vector that
had been treated with NdeI and BamHI. All of the con-
structs were confirmed by DNA sequencing analysis.
Purification of recombinant S-HDAg by DEAE-
cellulose (DE-52) chromatography
To express and purify the recombinant S-HDAg in E.
coli, an overnight culture of BL21DE3 cells transformed
with the plasmid was inoculated into 1 L of LB medium
with 50 mg/ml ampicillin at 37°C. After cell density
reached 0.5 at OD600, 0.2 mM IPTG was added to the
media to induce the S-HDAg expression after which the
culture was further incubated at 28°C for 18 h. E. coli
cells were harvested by centrifugation at 4°C and resus-
pended in 50 ml of ice-cold buffer A (50 mM Tris-HCl [pH
7.4], 1 mM EGTA, 1 mM EDTA, 0.2 mM PMSF, 10% glyc-
erol). The cell suspension was sonicated on ice three
times for 20 s each, and centrifuged at 10,000 rpm for 15
min. The supernatant was applied onto a DEAE-cellulose
(Whatman, Clifton, NJ) column (2.5 3 45 cm) preequili-
brated with 150 mM NaCl in buffer A. After the sample
was loaded, the column was washed with 300 ml of 150
mM NaCl in buffer A and eluted with 200 ml of 750 mM
b
sNaCl in buffer A. Aliquots of each fraction were analyzed
on a 12.5% SDS–polyacrylamide gel. Proteins were visu-
alized by staining with Coomassie blue.
Fractions containing S-HDAg were pooled and dia-
lyzed against 1 L of buffer A at 4°C overnight. The
dialyzed sample was loaded onto a smaller DEAE-cellu-
lose column (2.5 3 18 cm) preequilibrated with 150 mM
NaCl in buffer A and eluted with 150 ml of 0.15–1.0 M
NaCl linear gradient in buffer A. Aliquots of each fraction
were analyzed on a 12.5% SDS–polyacrylamide gel.
Affinity purification of S-HDAg by phosphocellulose
(P11) chromatography
Fractions containing S-HDAg from the second DEAE-
cellulose chromatography were pooled and affinity-puri-
fied by a phosphocellulose (Whatman) column (2.5 3 6.0
cm) preequilibrated with buffer A. The column was
washed with 40 ml of 1 M NaCl in buffer A, and proteins
were eluted with 40 ml of 0.2 M K2HPO4 and 0.8 M NaCl
in buffer A. Aliquots of the fractions were analyzed on a
12.5% SDS–polyacrylamide gel. Proteins were visualized
by staining with Coomassie blue.
Concentration of S-HDAg by SP–Sepharose high-
performance (SP-HP) chromatography
To obtain a high concentration of S-HDAg for gel
filtration analysis, affinity-purified S-HDAg was concen-
trated by a small SP–Sepharose HP (Pharmacia Biotech,
Piscataway, NJ) column (8 3 20 mm) preequilibrated with
buffer A. S-HDAg was eluted with 10 ml of 1 M of NaCl in
buffer A.
Purification of L-HDAg expressed in E. coli
The purification procedures for L-HDAg were similar to
those for S-HDAg as described above, except that 3 L of
B media containing E. coli cells were induced by IPTG
t 37°C. After phosphocellulose chromatography,
-HDAg was further purified with a UNO-S cation ex-
hange column (Bio-Rad, Richmond, CA) and eluted with
0.15–1.0 M NaCl gradient. The distribution of L-HDAg
as monitored by Western blot analysis.
nalysis of recombinant S-HDAg by gel filtration on
uperose 12 column
To determine the size of the recombinant S-HDAg,
-HDAg purified as described above was analyzed by
el filtration in buffer A containing 700 mM NaCl and 0.1%
riton X-100 but without glycerol. S-HDAg was loaded
nto a Superose 12 column (Pharmacia Biotech) with a
low rate of 0.4 ml/min, and 0.4-ml fractions were col-
ected. The protein molecular-weight standards were
lue dextran (Vo), gamma globulin (160 kDa), bovine
erum albumin (68 kDa), and cytochrome C (12.4 kDa).
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585RECOMBINANT HEPATITIS DELTA ANTIGEN AND RNA REPLICATIONAfter gel filtration, the S-HDAg was pooled and concen-
trated with SP–Sepharose column.
In vitro transcription
Genomic HDV RNA was transcribed from pKS/HDV1.9
(Jeng et al., 1996), which synthesizes a 1.9-kb RNA that is
slightly longer than the genome size, with T7 MEGAscript
(Ambion, Austin, TX) after linearization of the plasmid by
EcoRV digestion. Antigenomic-sense HDV RNA was syn-
thesized using SP6 MEGAscript (Ambion) from the same
plasmid after it was linearized by SnaBI. The capped
mRNA encoding S-HDAg was transcribed from plasmid
PX9 as previously described (Modahl and Lai, 1998).
Cell culture
Cos7 cells were cultured at 37°C in 35-mm-diameter
dishes in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 5% fetal bovine serum, 100 IU/ml of
penicillin, and 100 mg/ml streptomycin.
Transfection of RNA–protein complex
Purified S-HDAg (1 ml, 0.4 mg) or L-HDAg (10 ml, 1 mg)
was mixed with the in vitro-transcribed HDV RNA (3 ml, 3
mg) in a final volume of 25 ml in 10 mM HEPES (pH 7.4)
at room temperature for 10 min. DOTAP (15 ml; Boehr-
inger Mannheim Biochemicals, Indianapolis, IN) and 10
mM HEPES buffer (pH 7.4) (35 ml) were preincubated at
oom temperature for 15 min before being mixed with the
NA–protein mixture for transfection. Cos7 cells grown
n 35-mm dishes at subconfluency were transfected with
ml of fresh medium and 75 ml of DOTAP–RNA–protein
ixture at 37°C for 16–20 h. Culture medium was re-
laced daily with 1 ml fresh medium until cells were
arvested.
estern blot analysis
At various time points after transfection, the trans-
ected cells were suspended in 150 ml RIPA buffer (1%
NP-40, 1% sodium deoxycholate, 0.1% SDS, 150 mM
NaCl, and 50 mM Tris–HCl, pH 8.0) in the presence of the
protease inhibitor cocktail (Boehringer Mannheim) and
incubated at 4°C for 10 min. The cell lysate was mixed
with 30 ml of SDS-loading buffer and boiled for 10 min
efore being separated on 10% polyacrylamide gel con-
aining SDS. The proteins were detected by the ECL
estern blot detection system (Amersham, Arlington
eights, IL) using a combination of three monoclonal
ntibodies against both forms of HDAg (Hwang and Lai,
993b).
orthern blot analysis
Total RNA was extracted from the transfected Cos7
ells by TRIzol reagent (Gibco BRL, Gaithersburg, MD),
nd 12 mg of cellular RNA was electrophoresed through1.2% agarose gel containing formaldehyde. RNA was
blotted onto a nitrocellulose membrane (Hybond-C extra;
Amersham) and probed with in vitro-transcribed
[32P]UTP-labeled HDV genomic RNA to detect antigeno-
ic RNA synthesis. To synthesize the genomic strand
NA probe, S29 plasmid (Modahl and Lai, 1998) was
inearized with EcoRV and transcribed with T7 RNA poly-
erase. 32P-labeled HDV (2 3 106 cpm/ml) genomic-
ense RNA probe was used.
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